

Fundamental dimension Equity attribute | CSGPPeer $33.92▼-4.32% Cap $13.74BP/E 184.6x QuantScore45/100 | APPFLeader $210.62▼-3.09% Cap $7.46BP/E 44.2x QuantScore65/100 | SPGIPeer $449.68▼-0.76% Cap $132.6BP/E 27.4x QuantScore61/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
66/100 |
85/100 |
74/100 |
Valuation Multiples, PEG & DCF upside | 14/100 | 43/100 | 61/100 |
Health Piotroski, Altman Z, leverage & liquidity | 67/100 | 100/100 | 66/100 |
Growth Revenue / earnings growth & margins | 50/100 | 58/100 | 42/100 |
Sentiment Analyst ratings, targets & revisions | 28/100 | 40/100 | 63/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 184.6x | 44.2x | 27.4x |
Forward P/E (next FY) | 24.8x | 30.8x | 25.2x |
EV / EBITDA (TTM) | 32.8x | 31.3x | 17.5x |
Price / Sales | 3.9x | 6.9x | 8.2x |
Price / Free Cash Flow | 44.1x | 26.5x | 23.8x |
PEG ratio | -6.00 | -2.92 | 1.05 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 8 / 9 | 7 / 9 |
Altman Z-Score | 4.58 (Safe) | 37.70 (Safe) | 4.24 (Safe) |
Total debt / equity | 0.15 | 0.04 | 0.50 |
Quick ratio | 2.2x | 4.0x | 1.0x |
Interest coverage | 5.4x | — | 23.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +18.7% | +19.7% | +7.9% |
Net income growth YoY | -95.0% | -30.9% | +16.1% |
Gross margin (TTM) | 76.5% | 63.3% | 70.9% |
Operating margin (FY) | -2.2% | 16.1% | 42.2% |
FCF margin (FY) | 1.3% | 25.1% | 35.6% |
5. Trailing price performancePrice change over period |
1M return | +20.8% | +3.1% | +11.7% |
3M return | +22.6% | +27.6% | +5.6% |
6M return | -6.9% | +24.4% | +3.1% |
Year to date | -49.6% | -9.5% | -13.8% |
1Y return | -56.6% | -14.1% | -8.0% |
3Y return | -52.2% | +19.5% | +29.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $20.63 -39.2% premium | $190.17 -9.7% premium | $254.05 -43.5% premium |
Wall Street consensus target | $36.36 +7.2% · range $26.00–$44.00 | $252.25 +19.8% · range $239.00–$280.00 | $506.71 +12.7% · range $477.00–$531.00 |
Consensus stance | 59% Buy33% Hold7% Sell | 67% Buy27% Hold7% Sell | 86% Buy14% Hold0% Sell |